AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimkacare M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Waywell Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimkacare M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabex Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue using this medication even if feeling well or if blood sugar is controlled; abrupt cessation can elevate blood glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive treatment plan incorporating a balanced diet, regular exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to address them. Maintain regular mealtimes and carry a rapid-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is unsuitable for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to use. Pregnant or lactating individuals should seek medical consultation before commencing treatment. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function may be recommended by your physician.

Uses of Glimkacare M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimkacare M 1mg/500mg Tablet:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimkacare M 1mg/500mg tablets with a meal.

Common Side effects of Glimkacare M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimkacare M 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Glimkacare M 1mg/500mg tablets should be administered with a meal.

How Glimkacare M 1mg/500mg Tablet works:

Glimkacare M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption with Glimkacare M 1mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimkacare M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Maternal use of Glimkacare M 1mg/500mg tablets while breastfeeding is contraindicated due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimkacare M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Physician consultation is essential. This medication is contraindicated for individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glimkacare M 1mg/500mg tablets cautiously. Dosage modification may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, Glimkacare M 1mg/500mg tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glimkacare M 1mg/500mg Tablet :

Should you forget a Glimkacare M 1mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimkacare M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glimkacare M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimkacare M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue use and seek immediate medical attention.
Glimkacare M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 DM.
Glimkacare M 1mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimkacare M 1mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimkacare M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimkacare M 1mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar, causing hypoglycemia, and heighten the risk of lactic acidosis.
Glimkacare M 1mg/500mg Ta...
49
MRP 57
14% off